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Studies have shown that approximately 10% of women 
lose more than 1.4 mg of iron per day through menstrual 
bleeding.1,2 Li et al3 estimated the average menstrual 
blood loss by weighing menstrual pads before and after 
use by their subjects (mean [SD], 59.3 [25.1] g/dL). They 
also estimated the average content of serum ferritin, free 
protoporphyrin, and hemoglobin as mean [SD] values of 
25.13 [14.33] ng/mL, 0.06 [0.01] µg/mL, and 131.61 [9.76] 
g/L, respectively.3 The total amount of blood loss during 
menstruation ranges from 30 to 180 ml, with an average 
of 80 ml per menstrual period.4 Also, it has been shown5 
that blood loss of 40 ml during menstruation yields an 
average loss of 1.6 mg of iron. Further, consecutive blood 
loss of more than 60 ml per menstrual period will deplete 
the body’s iron stores; loss of more than 80 ml may 
indicate clinical anemia.7 Of importance, iron deficiency 
affects approximately 20% to 25% of the world’s 
population, predominantly children and women. It has 
been domonstrated8 that iron deficiency is more likely  
in women of reproductive age because of menstrual 
blood loss.
Approximately 65% of iron is stored in hemoglobin 
(Hb). Iron is involved in energy metabolism, cell growth, 
oxygen binding, enzyme reactions, and synthesis of 
neurotransmitters.9 It has been reported10 that 3 to 24 
mg of iron is lost during each menstrual cycle. Emerging 
evidence suggests that iron deficiency without anemia 
can have negative consequences in adults, particularly 
neurocognitive disorders.8 In addition, the implications 
of iron deficiency may include decreased work capacity, 
 
ABSTRACT
Background: Low hemoglobin (Hb) and iron deficiency among child 
bearing females have been linked to decreased immune system 
function, impaired cognitive functioning and complications in 
pregnancy. 
 
Methods: A total of 106 blood samples from apparently healthy 
nulliparous female students were assayed for Hb and serum iron 
concentrations using the cyanmethemoglobin and bathophenanthroline 
methods, respectively, to evaluate changes that may occur in these 
parameters at different phases of the reproductive cycle.
 
Results: The mean (SD) Hb values during the ovulatory, menstrual, 
and follicular phases were 13.27 (1.14) g/dL, 12.05 (1.31) g/dL, and 
12.23 (1. 56) g/dL, respectively. The prevalence of anemia (Hb<12 
g/dL) was reported among 21 (19.8%) subjects, and 31 subjects 
declined to complete their samples collection. The mean serum 
iron concentrations during the 3 phases were 92.98 (18.25) µg/dL, 
79.90 (13.14) µg/dL and 70.85 (18.65) µg/dL, respectively. A total of 
28 (26.4%) study participants showed iron deficiency (serum level, 
<65 µg/dL). These variations in the values of Hb and serum iron 
concentrations were statistically significant in the 3 phases. However, 
no significant difference was observed in Hb concentrations between 
the menstrual and follicular phases. Of interest, a positive correlation 
was observed between the hemoglobin and serum iron concentrations 
within the phases, with the exception of a few cases that showed 
negative correlations. 
 
Conclusion: Menstruation has been shown to be the major cause of 
anemia and iron deficiency in nulliparous women. A prophylactic dose of 
iron and folate supplements may be indicated for menstruating females 
to cushion the adverse effects of menstruation on hematologic status.  
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decreased immune system functioning, impaired cognitive 
functioning and memory and complications in pregnancy.9 
Conversely, Ba et al11 stated that iron overload is a 
significant risk factor in the development of hepathocellular 
carcinoma, the third-most-common cause of cancer-
related death. A study12 carried out with baboons showed 
that hemoglobin, red blood cells and white blood cell 
counts were low during the menstrual phase and high in 
the follicular phase.12
A substantial proportion of women in developing countries 
such as Nigeria have been reported to enter pregnancy 
with inadequate iron stores, predisposing them to iron 
deficiency anemia.13 However, heavy menstrual blood loss 
is the most important factor contributing to iron-deficiency 
anemia in women.14
Recent evidence15 suggests that poor fetal growth 
is associated with preconception anemia. As a 
precautionary measure, iron and folate supplements 
taken before conception may help ameliorate pre-existing 
anemia caused by menstruation.15 Also, the use of oral 
contraceptives reduces the volume of blood loss during 
menstruation and thereby increases iron stores.16 Our study 
was designed to asses hemoglobin and serum iron status 
in nulliparous women at various phases of the reproductive 
cycle with a view toward identifying changes that may 




Forty-six nulliparous female students from the Federal 
School of Medical Laboratory Science and the School 
of Nursing and Midwifery in Jos, Nigeria, consented to 
participate in the study. Study participants were between 
the ages of 19 and 30 years. The average menstrual cycle 
of the participants was 27 days, with 4 days of menstrual 
bleeding. Women with heavy menstrual bleeding or a 
history of amenorrhea were excluded from the study. 
Sample Size/Study Design
A total of 106 blood samples were collected for the 
study. Venous blood samples were collected from the 
study participants at the 3 major reproductive phases: 
the ovulatory phase (2 weeks before menstruation), the 
menstrual phase (1 day after the onset of menstruation), 
and the follicular phase (1 day after cessation of 
menstruation).
Sample Collection
A sample of 9.0 ml of venous blood was collected by 
venipuncture from each subject at the 3 different phases 
of the menstrual cycle, between the hours of 8:00 am 
and 12:00 pm. Six ml of the sample were each dispensed 
into a Z/10 Sterilin plastic container (ThermoFisher 
Scientific Inc, Waltham, MA). The bottles were each 
labeled with the name and the menstrual phase of the 
subject. The samples were allowed to clot for 10 minutes 
at room temperature. The was centrifuged at 3000 
revolution per minutes for 10 minutes, and the serum 
was transferred into a Z/5 Sterilin plastic container 
(ThermoFisher Scientific Inc). The serum specimens 
were analyzed for iron using the bathophenanthroline 
method.17 Three ml of blood sample was transferred 
into a labeled specimen container that included 
ethylenediaminetetraacetic acid (EDTA), and the contents 
of the bottle were thoroughly mixed. The specimens were 
analyzed for hemoglobin using the cyanmethemoglobin 
method.18
Determination of Iron Concentration  
Using the Bathophenanthroline Method 
We used a method reported by Peters et al.17 Iron was 
released from transferrin by acidification with hydrochloric 
acid, the specimens were deproteinized with trichloroacetic 
acid, centrifuged, and ferric ions in the supernatant 
were reduced to ferrous ions using thioglycolic acid. 
Bathophenanthroline was added and absorbance was 
measured colorimetrically at 540-nm. 
Hemoglobin Estimation Using 
Cyanmethemoglobin Method
Whole blood was diluted with Drabkin’s solution, (buffered 
potassium ferricyanide and potassium cyanide). Potassium 
ferricyanide converts hemoglobin to methemoglobin, 
which is converted to cyanmethemoglobin by the action 
of potassium cyanide. The absorbance was measured 
colorimetrically at 540 nm. 
Data Management and Statistical Applications
The study data were analyzed using SPSS, version 15.0 
(IBM Corporation, Armonk, NY). The mean values of 
hemoglobin and serum iron concentrations, standard 
deviations, percentage, and Pearson correlation were 
determined. Relevant hypotheses were tested using the  
t test and χ2 test, as appropriate.
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Results
The mean (SD) hemoglobin values at the ovulatory, 
menstrual, and follicular phases were 13.27 (1.14) g/dL, 
12.05 (1.31) g/dL, and 12.23 (1 56) g/dL, respectively (Table 
1). Statistical comparison indicated a significant reduction 
in hemoglobin concentration between the ovulatory and 
menstrual phases. Significant changes also were observed 
between the ovulatory and follicular phases. No significant 
differences were observed between the menstrual and 
follicular phases (Table 1). Anemia (Hb<12 g/dL) was 
revealed in 21 (19.8%) subjects: 2 (9.5%) in the ovulatory 
phase, 7 (33.3%) in the menstrual phase, and 12 (57.1%) in 
the follicular phase. 
The mean (SD) serum iron concentrations during the 
ovulatory, menstrual, and follicular phases were 92.98 
(18.25) µg/dL, 79.90 (13.14) µg/dL, and 70.85 (18.65) µg/
dL, respectively (Table 2). Twenty-eight study participants 
(26.4%) were iron deficit (serum level, <65 µg/dL), of whom 
4 (14.3%) were in the ovulatory phase, 4 (14.3%) were in 
the menstrual phase, and 20 (71.4%) were in the follicular 
phase. Significant differences were found in serum iron 
concentrations between the ovulatory and menstrual 
phases, the menstrual and follicular phases, and the 
ovulatory and follicular phases (Table 2).
Pearson correlation coefficients for hemoglobin versus 
serum iron concentrations during the 3 phases of 
the reproductive cycle are shown in Table 3. Positive 
correlations were found in all 3 phases, although there 
were 3 comparisons that showed a negative correlation. 
Hemoglobin and serum iron mean (SD) concentrations were 
decreased during menstruation, and in the follicular phase, 
whereas hemoglobin increased in the follicular phase. 
Discussion
The results of this study showed that menstruation affects 
the hemoglobin and iron concentrations in nulliparous 
women. Despite the finding of a significant reduction in 
hemoglobin concentrations between the ovulatory and 
menstrual phases and the ovulatory and follicular phases, 
no significant decrease was observed in the Hb values 
between the menstrual and follicular phases. The lowest 
mean (SD) Hb value was recorded in the menstrual phase 
of the reproductive cycle; by implication, this means that 
the menstrual phase could be a potential cause of anemia 
Table 1. Hemoglobin Concentrations During 
the 3 Phases of the Reproductive Cycle 
Among Nulliparous Women Aged 19 to  
30 Years
Phase Subjects, No. Mean (SD)a t Test P Value
Ovulatory 31 13.27 (1.14)  3.734 <.001
Menstrual 25 12.05 (1.31)  
    
Ovulatory 31 13.27 (1.14) 3.157 .002
Follicular 44 12.23 (1.56)  
    
Menstrual 25 12.05 (1.31) –0.498 .62
Follicular 44 12.23 (1.56)  
aMeasured in g/dL.
Table 2. Serum Iron Concentrations During the 
3 Phases of the Reproductive Cycle Among 
Nulliparous Women Aged 19 to 30 Years
Phase Subjects, No. Mean (SD)a t Test P Value
Ovulatory 33 92.98 (18.25) 3.117 <.001
Menstrual 27 79.90 (13.14)  
    
Ovulatory 33 92.98 (18.28) 5.248 <.001
Follicular 46 70.85 (18.65)  
    
Menstrual 27 79.90 (13.14) 2.229 .03
Follicular 46 70.85 (18.65)  
aMeasured in µg/dL.
Table 3. Pearson Correlation of the Mean 
(SD) Values of Hemoglobin and Serum Iron 
Concentrations During the 3 Phases of the 
Reproductive Cycle Among Nulliparous 
Women Aged 19 to 30 Years
  Serum Iron
Hemoglobin Ovulatory Menstrual Follicular
Ovulatory  
 Pearson correlation –0.014 0.049 –0.041
 P Value .94 .82 .84
 Subjects, No. 31 25 26
Menstrual 
 Pearson correlation –0.039 0.038 0.069
 P Value .85 .86 .74
 Subjects, No. 25 25 25
Follicular 
 Pearson correlation 0.298 0.301 0.046
 P Value .148 .144 .769
 Subjects, No. 25 25 44
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among nulliparous women. Anemia was identified in 21 
(19.8%) subjects, of whom 2 (9.5%) were in the ovulatory 
phase, 7 (33.3%) in the menstrual phase, and 12 (57.1%) in 
the follicular phase. By comparison, a case study carried 
out on baboons12 revealed that nulliparous females in the 
study had decreased hemoglobin concentration during the 
menstrual phase and increased serum iron concentration 
levels in the follicular phase.
The mean (SD) serum iron concentrations were 92.98 
(18.25) µg/dL, 79.90 (13.14) µg/dL, and 70.85 (18.65)  
µg/dL in the ovulatory, menstrual, and follicular phases, 
respectively. Significant reduction in serum iron was 
observed in the 3 phases (Table 2). Iron deficiency was 
discovered in 28 (26.4%) women, of whom 4 (14.3%) 
were in the ovulatory phase, 4 (14.3%) in the menstrual 
phase, and 20 (71.4%) in the follicular phase. Mean 
hemoglobin and iron concentrations were decreased 
during menstruation and serum iron further decreased in 
the follicular phase, whereas hemoglobin increased in the 
follicular phase. 
Conclusion
Menstruation has been shown to be a major cause of 
anemia and iron deficit in nulliparous women. Reduction in 
serum iron has been reported to adversely affect cognitive 
and memory capacity. The adverse effects of menstruation 
could be linked to complications associated with 
pregnancy and anemia. A prophylactic dose of hematinics 
or iron and folate supplements may be indicated for 
menstruating women to offset the effects of menstruation 
on Hb and serum iron levels.  LM
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